SFTPB and non-small cell lung carcinoma: Finally, we demonstrated that the reduction of SFTPB mRNA in NSCLC disrupts the negative regulation of pro-SFTPB on eIF4F complex formation, leading to activation of the eIF4F translation pathway and ultimately promoting tumor stemness and immune escape.